2005, Documentation and Pharmaceutical Manufacturing

Search:

DAY

WEEK

MONTH

YEAR

Select your country:
Sign up | Log in

2005

Documentation

Pharmaceutical Manufacturing

Ensuring Product Safety: U.S. FDA Guidance on Testing High-Risk Drug Components for Diethylene Glycol and Ethylene Glycol

Quality Matters

SEPTEMBER 15, 2023

FDA Guidance on Testing High-Risk Drug Components for Diethylene Glycol and Ethylene Glycol (Disclaimer: The article below includes a discussion of key points of the guidance document. It is not the guidance document, nor it is an alternative to the guidance document. The guidance document is available here: [link].)

Documentation

Documentation Compounding Pharmaceutical Manufacturing

Corrective and Preventive Action (CAPA) Procedure for GMP

GMPSOP

MARCH 17, 2023

ISO 9000:2005 Sec. Additional documents included each month. Subscribe Corrective action vs preventive action examples In pharmaceuticals, corrective and preventive action (CAPA), is conducted at the implementation stage of most quality concern investigations. Additional documents included each month. When to raise CAPA?

Documentation

Documentation Packaging Process Improvement Pharmaceutical Manufacturing

Pharmacist Digest

Ensuring Product Safety: U.S. FDA Guidance on Testing High-Risk Drug Components for Diethylene Glycol and Ethylene Glycol

Corrective and Preventive Action (CAPA) Procedure for GMP

Stay Connected